Amer Hamadé, Lucas Jambert, Jonathan Tousch, Philippe Feuerstein, Karima Hammas, Samuel Degoul, Naouel Bensalah, Pierre Michel, Michèle Lehn-Hogg, Golnaz Obringer, Nathalie Buschenrieder, Philippe Nusbaum, Nayrouz Barakat, Marjolaine Talbot, Dominique Stephan, Bastien Woehl
{"title":"Withdrawal Notice: Is There a Link between Lung Parenchyma Lesions, BMI, CRP and D-dimer in COVID-19 Patients Who Had Acute Pulmonary Embolism?","authors":"Amer Hamadé, Lucas Jambert, Jonathan Tousch, Philippe Feuerstein, Karima Hammas, Samuel Degoul, Naouel Bensalah, Pierre Michel, Michèle Lehn-Hogg, Golnaz Obringer, Nathalie Buschenrieder, Philippe Nusbaum, Nayrouz Barakat, Marjolaine Talbot, Dominique Stephan, Bastien Woehl","doi":"10.2174/1871529X21666210812102024","DOIUrl":null,"url":null,"abstract":"<p><p>The article has been withdrawn at the request of the editor of the journal Cardiovascular & Hematological Disorders-Drug\nTargets due to incoherent content.</p><p><p>Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.</p><p><p>The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.</p><p><strong>Bentham science disclaimer: </strong>It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously\nsubmitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere\nmust be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting\nthe article for publication the authors agree that the publishers have the legal right to take appropriate action against the\nauthors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright\nof their article is transferred to the publishers if and when the article is accepted for publication.</p>","PeriodicalId":9543,"journal":{"name":"Cardiovascular and Hematological Disorders - Drug Targets","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular and Hematological Disorders - Drug Targets","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871529X21666210812102024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
The article has been withdrawn at the request of the editor of the journal Cardiovascular & Hematological Disorders-Drug
Targets due to incoherent content.
Bentham Science apologizes to the readers of the journal for any inconvenience this may have caused.
The Bentham Editorial Policy on Article Withdrawal can be found at https://benthamscience.com/editorial-policies-main.php.
Bentham science disclaimer: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously
submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere
must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting
the article for publication the authors agree that the publishers have the legal right to take appropriate action against the
authors, if plagiarism or fabricated information is discovered. By submitting a manuscript the authors agree that the copyright
of their article is transferred to the publishers if and when the article is accepted for publication.
期刊介绍:
Cardiovascular & Hematological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow.